Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

31.08
Delayed Data
As of Aug 18
 +0.05 / +0.16%
Today’s Change
20.68
Today|||52-Week Range
40.83
+7.77%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Moore Terrence O
EVP & Chief Commercial Officer
Sale2/14/201789,088$39.69$3.5M-21.69%
Moore Terrence O
EVP & Chief Commercial Officer
Sale2/16/201766,752$39.88$2.7M-20.75%
Moore Terrence O
EVP & Chief Commercial Officer
Buy2/14/201787,128$19.61$1.7M-21.69%
Baity Glenn F
General Counsel & Executive Vice President
Sale7/20/201738,097$30.00$1.1M+3.29%
Baity Glenn F
General Counsel & Executive Vice President
Sale2/01/201731,078$35.15$1.1M-9.89%
Baity Glenn F
General Counsel & Executive Vice President
Sale2/14/201726,365$39.66$1.0M-21.69%
Moore Terrence O
EVP & Chief Commercial Officer
Buy2/16/201729,644$34.45$1.0M-20.75%
Moore Terrence O
EVP & Chief Commercial Officer
Buy2/16/201719,687$27.20$535.5K-20.75%
Baity Glenn F
General Counsel & Executive Vice President
Sale8/09/201714,322$34.88$499.6K-6.41%
Moore Terrence O
EVP & Chief Commercial Officer
Buy2/16/201717,421$19.61$341.6K-20.75%
Page of 4